Europe Should Pay Drug Prices More In Line With US, Two Pharma CEOs Argue

 
• By Kevin Grogan
  
Paul Hudson and Vas Narasimhan
Paul Hudson (L) and Vas Narasimhan said Europe is penalizing innovation. (Illustration by Kosh Naran)

More from Pricing Debate

More from Market Access